Guanajuato Silver - The company's El Cubo Mines Complex.
The company's El Cubo Mines Complex.
Source: Guanajuato Silver.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Guanajuato Silver (GSVR) is announcing a new significant equity shareholder in the U.S.
  • A leading institutional fund purchased approximately 24,000,000 GSVR common shares
  • The acquisition represents the majority of the position previously held by Great Panther Mining
  • Guanajuato Silver is a precious metals producer reactivating past-producing silver and gold mines in central Mexico
  • Guanajuato Silver (GSVR) is up by 4.17 per cent, trading at $0.375 per share

Guanajuato Silver (GSVR) is announcing a new significant equity shareholder in the U.S.

A leading institutional fund purchased approximately 24,000,000 GSVR common shares, which represents the majority of the position previously held by Great Panther Mining.

Guanajuato purchased the shares through a Great Panther-appointed trustee.

The news follows Guanajuato’s doubling of quarter-over-quarter production in Q3, record Q4 production, and its listing on London’s Aquis Exchange.

“The addition of this new strategic investor is a major endorsement of the quality of our projects, our vision for the future, and the ability of our management team to execute,” stated James Anderson, Guanajuato’s Chairman and CEO. “The sale of this large share block to a significant long-term shareholder strengthens our capital structure as we look to further advance our production profile in Mexico.”

Guanajuato Silver is a precious metals producer reactivating past-producing silver and gold mines in central Mexico. It offers silver and gold concentrates from three mines in the state of Guanajuato, with lead and zinc concentrates available from its mine in Durango.

Guanajuato Silver (GSVR) is up by 4.17 per cent, trading at $0.375 per share as of 10:12 am EST.


More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.